From an overall perspective, the tumor inhibition efficacy of BSA-Man@Mn2+-Ft@Lap nanoagonist on STING-KO mice was significantly lower than that on the wild-type group (WT), evidenced by the more rapid tumor growth in terms of volume and weight (Fig. 8a–d). Here, STING1 is linked to neoplasm.